Core Viewpoint - The company emphasizes its focus on drug-coated balloons and specialized balloons as key development areas, highlighting the competitive advantage of rapamycin-based drug balloons [1] Group 1: Company Strategy - The company's development strategy aims to achieve integrated solutions while adhering to the concept of "intervention without implantation" [1] - The company plans to pursue both horizontal and vertical development, with horizontal development involving a range of product lines such as drug-coated balloons, specialized balloons, and intravascular imaging [1] - Vertical development focuses on the renewal and upgrading of existing products [1]